The influence of nevirapine and efavirenz-based anti-retroviral therapy on the pharmacokinetics of lumefantrine and anti-malarial dose recommendation in HIV-malaria co-treatment

BACKGROUND: HIV-malaria co-infected patients in most parts of sub-Saharan Africa are treated with both artemether-lumefantrine (AL) and efavirenz (EFV) or nevirapine (NVP)-based antiretroviral therapy (ART). EFV, NVP, artemether and lumefantrine are substrates, inhibitors or inducers of CYP3A4 and C...

Descripción completa

Detalles Bibliográficos
Autores principales: Maganda, Betty A, Ngaimisi, Eliford, Kamuhabwa, Appolinary AR, Aklillu, Eleni, Minzi, Omary MS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424554/
https://www.ncbi.nlm.nih.gov/pubmed/25906774
http://dx.doi.org/10.1186/s12936-015-0695-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424554/
https://www.ncbi.nlm.nih.gov/pubmed/25906774
http://dx.doi.org/10.1186/s12936-015-0695-2

Ejemplares similares